Ovarian Cancer, news on ovarian caner, early detection of ovarian cancer and treatment, symptoms and signs of ovarian cancer, clinical trials and ovarian cancer information.
While ovarian cancer accounts for only 6% percent of all cancers among women, its mortality rate is very high, ranking it the fourth highest cancer killer of women.
Due to considerable risk of ovarian cancer and its high lethality, women would be best advised to undergo prophylactic salpinoophorectomy, which essentially eliminates the risk of ovarian cancer.
Education about ovarian cancer is essential, as almost 70 percent of women with the common epithelial ovarian cancer are not diagnosed until the disease is advanced in stage.
BioNumerik Commences Ovarian Cancer Trial On Karenitecin BioNumerik Pharmaceuticals initiates global Phase III clinical trial of BioNumerik's anticancer drug candidate known as Karenitecin in advanced ovarian cancer patients.
Link Between Cell Survival Proteins, Ovarian Cancer Aggressiveness Scientific team has found that the elevated levels of certain proteins typically associated with keeping cancer cells alive may actually correspond with improved patient survival in ovarian cancer.